Discovery of a new drug with high potential to treat Ewing sarcoma, an often deadly cancer of children and young adults, and the previously unknown mechanism behind it, come hand-in-hand in a new study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah. The report appears in today’s online issue of the journal Oncogene. “Ewing sarcoma is almost always caused by a cancer-causing protein called EWS/FLI,” said Stephen Lessnick, M.D., Ph.D. Read more here.
Study mentioned: Sankar S, et al. Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma. Oncogene. 2012 Nov 26. [Epub ahead of print] PMID: 23178492
No comments:
Post a Comment